Why Are Your Google Ads Disapproved for Telehealth, and How Do You Fix It?

The three reasons Google rejects telehealth ads

Almost every telehealth disapproval traces back to one of three causes, and they require completely different fixes. MedScale works only with telehealth advertisers, and the pattern holds across accounts: teams rewrite creative when the real problem is an account-level certification gap, then rewrite it again when the real problem is on the landing page.

• The advertiser is not certified to promote telemedicine services or prescription medication in the countries being targeted.
• The destination page carries claims, products, or language that Google's healthcare policies treat as unsupported or prohibited.
• The campaign promotes a substance or service that Google restricts regardless of who is advertising it.

Diagnosing which of the three applies before touching the creative saves the most time, because only the third is a genuine dead end.

Certification is an account-level gate, not a creative problem

Google requires advertisers promoting telemedicine services and prescription medication to be certified before those ads can run, and certification is granted to the advertiser rather than to an individual ad. An uncertified account will see disapprovals across every campaign at once, which is the clearest diagnostic signal available.

If disapprovals arrived suddenly and affected everything simultaneously, the cause is almost never creative. It is an account status change, a policy update that expanded what requires certification, or a certification that lapsed. Rewriting ad copy in that situation produces new ads that fail in exactly the same way.

The landing page is part of what gets reviewed

Google evaluates the destination, not only the ad. A compliant ad pointing at a page that sells a restricted product, makes outcome guarantees, or omits required information can be disapproved on the basis of the page alone.

This is the most commonly missed cause in telehealth, because the ad and the website are usually owned by different teams. MedScale reviews the destination alongside the creative for that reason, and treats the intake flow as part of the ad rather than as something downstream of it.

How to read a Google disapproval properly

The policy name attached to a disapproval is the most useful information in the notice, and it is routinely ignored. A rejection citing healthcare and medicines is a different problem from one citing misrepresentation, and they have different remedies.

• Note the exact policy cited, not just that the ad was rejected.
• Check whether the disapproval is isolated or account-wide, which separates creative problems from certification problems.
• Check whether the destination URL changed recently, since page edits can trigger re-review of previously approved ads.

Why appealing first is usually the wrong move

An appeal filed while the underlying issue is still live tends to confirm the original decision, and repeated unsuccessful appeals are not a neutral event for the account. The productive order is to identify the cited policy, correct the ad and the destination, and only then request review.

MedScale treats disapproval volume as a signal worth tracking over time rather than a routine cost of running healthcare campaigns. A campaign hitting its targets while accumulating rejections is building a record against the account.